583 related articles for article (PubMed ID: 27566967)
1. Sleep quality and daytime sleepiness in patients treated with adjunctive perampanel for focal seizures.
Toledo M; Gonzalez-Cuevas M; Miró-Lladó J; Molins-Albanell A; Falip M; Martinez AB; Fernandez S; Quintana M; Cambrodi R; Santamarina E; Salas-Puig J
Epilepsy Behav; 2016 Oct; 63():57-62. PubMed ID: 27566967
[TBL] [Abstract][Full Text] [Related]
2. Perampanel effect on sleep architecture in patients with epilepsy.
Rocamora R; Álvarez I; Chavarría B; Principe A
Seizure; 2020 Feb; 76():137-142. PubMed ID: 32086182
[TBL] [Abstract][Full Text] [Related]
3. Effect of adjunctive perampanel on the quality of sleep and daytime somnolence in patients with epilepsy.
González-Cuevas M; Romero O; Toledo M; Quintana M; Cambrodí R; Santamarina E; Jurado MJ; Ferrer A; Salas-Puig X
Epilepsy Behav Case Rep; 2017; 7():13-15. PubMed ID: 28066710
[TBL] [Abstract][Full Text] [Related]
4. Sleep-wake cycle and daytime sleepiness in patients with epilepsy after initiating perampanel as adjunctive therapy.
Fernandes M; Lupo C; Spanetta M; De Masi C; Placidi F; Izzi F; Mercuri NB; Liguori C
Neurol Sci; 2023 Apr; 44(4):1361-1368. PubMed ID: 36481971
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of adjunctive perampanel 4 mg/d for the treatment of focal seizures: A pooled post hoc analysis of four randomized, double-blind, phase III studies.
Steinhoff BJ; Patten A; Williams B; Malhotra M
Epilepsia; 2020 Feb; 61(2):278-286. PubMed ID: 31944276
[TBL] [Abstract][Full Text] [Related]
6. Depressive symptoms predict the quality of sleep in patients with partial epilepsy--A combined retrospective and prospective study.
Moser D; Pablik E; Aull-Watschinger S; Pataraia E; Wöber C; Seidel S
Epilepsy Behav; 2015 Jun; 47():104-10. PubMed ID: 25982882
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of adjunctive perampanel on cognition in adolescents with partial seizures.
Piña-Garza JE; Lagae L; Villanueva V; Renfroe JB; Laurenza A; Williams B; Kumar D; Meador KJ
Epilepsy Behav; 2018 Jun; 83():50-58. PubMed ID: 29653338
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the long-term efficacy and safety of adjunctive perampanel in tonic-clonic seizures: Analysis of four open-label extension studies.
Rektor I; Krauss GL; Inoue Y; Kaneko S; Williams B; Patten A; Malhotra M; Laurenza A; Wechsler RT
Epilepsia; 2020 Jul; 61(7):1491-1502. PubMed ID: 32645213
[TBL] [Abstract][Full Text] [Related]
9. Daytime sleepiness in epilepsy patients with special attention to traffic accidents.
Matsuoka E; Saji M; Kanemoto K
Seizure; 2019 Jul; 69():279-282. PubMed ID: 31132615
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and safety of perampanel as early add-on treatment in patients with epilepsy and focal seizures in the routine clinical practice: Spain prospective study (PERADON).
Abril Jaramillo J; Estévez María JC; Girón Úbeda JM; Vega López Ó; Calzado Rivas ME; Pérez Díaz H; García Martín G; Vila Herrero E; Chamorro-Muñoz M; Vázquez F; De la Fuente C; Redondo L; Peláez N; Santágueda P; Rodríguez Uranga JJ
Epilepsy Behav; 2020 Jan; 102():106655. PubMed ID: 31812902
[TBL] [Abstract][Full Text] [Related]
11. Adjunctive perampanel in partial-onset seizures: Asia-Pacific, randomized phase III study.
Nishida T; Lee SK; Inoue Y; Saeki K; Ishikawa K; Kaneko S
Acta Neurol Scand; 2018 Apr; 137(4):392-399. PubMed ID: 29250772
[TBL] [Abstract][Full Text] [Related]
12. Sleep quality and related clinical features in patients with epilepsy: A preliminary report.
Çilliler AE; Güven B
Epilepsy Behav; 2020 Jan; 102():106661. PubMed ID: 31766003
[TBL] [Abstract][Full Text] [Related]
13. Sustained seizure freedom with adjunctive perampanel in patients with convulsive seizures: Post hoc analysis of open-label extension studies 307 and 332.
Resnick T; Patten A; Ngo LY; Malhotra M
Epilepsy Behav; 2022 Mar; 128():108528. PubMed ID: 35078116
[TBL] [Abstract][Full Text] [Related]
14. Wake up to sleep: The effects of lacosamide on daytime sleepiness in adults with epilepsy.
Foldvary-Schaefer N; Neme-Mercante S; Andrews N; Bruton M; Wang L; Morrison S; Bena J; Grigg-Damberger M
Epilepsy Behav; 2017 Oct; 75():176-182. PubMed ID: 28866338
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305.
French JA; Krauss GL; Steinhoff BJ; Squillacote D; Yang H; Kumar D; Laurenza A
Epilepsia; 2013 Jan; 54(1):117-25. PubMed ID: 22905857
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of perampanel in patients with drug-resistant partial seizures after conversion from double-blind placebo to open-label perampanel.
Montouris G; Yang H; Williams B; Zhou S; Laurenza A; Fain R
Epilepsy Res; 2015 Aug; 114():131-40. PubMed ID: 26088896
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of adjunct perampanel based on number of antiepileptic drugs at baseline and baseline predictors of efficacy: A phase III post-hoc analysis.
Glauser T; Laurenza A; Yang H; Williams B; Ma T; Fain R
Epilepsy Res; 2016 Jan; 119():34-40. PubMed ID: 26656783
[TBL] [Abstract][Full Text] [Related]
18. A post hoc analysis of the long-term safety and efficacy of perampanel in Asian patients with epilepsy.
Inoue Y; Kaneko S; Hsieh PF; Meshram C; Lee SA; Aziz ZA; Nabangchang C; Dash A
Epilepsia; 2019 Mar; 60 Suppl 1():60-67. PubMed ID: 30869167
[TBL] [Abstract][Full Text] [Related]
19. Safety, efficacy and outcome-related factors of perampanel over 12 months in a real-world setting: The FYDATA study.
Villanueva V; Garcés M; López-González FJ; Rodriguez-Osorio X; Toledo M; Salas-Puig J; González-Cuevas M; Campos D; Serratosa JM; González-Giráldez B; Mauri JA; Camacho JL; Suller A; Carreño M; Gómez JB; Montoya J; Rodríguez-Uranga J; Saiz-Diaz R; González-de la Aleja J; Castillo A; López-Trigo J; Poza JJ; Flores J; Querol R; Ojeda J; Giner P; Molins A; Esteve P; Baiges JJ
Epilepsy Res; 2016 Oct; 126():201-10. PubMed ID: 27521586
[TBL] [Abstract][Full Text] [Related]
20. Impact of sleep disorders on the risk of seizure recurrence in juvenile myoclonic epilepsy.
Buratti L; Natanti A; Viticchi G; Falsetti L; Lattanzi S; Pulcini A; Petrelli C; Provinciali L; Silvestrini M
Epilepsy Behav; 2018 Mar; 80():21-24. PubMed ID: 29396358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
